NAVAN Technologies
PrivateLast Round
Seed
Apr 25, 2019
Total Funding Raised
$750,000
Company Overview
NAVAN (Biotechnology) is a biotechnology company that provides a platform for cellular engineering, enabling efficient and low-toxicity delivery of reprogramming agents and other materials into immune cells for therapeutic and regenerative applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Hardware + Subscription
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NAVAN Technologies Comps
Public and private peers based on sector, stage, and business model.
NAVAN Technologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Apr 25, 2019 | ||||
| Grant | Mar 1, 2018 |
Key People
Founding team and executive leadership
NAVAN Technologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hemi Ventures | Seed |
| Amgen Ventures | Seed |
| High-Tech Gründerfonds | Seed |
| National Science Foundation | Grant |
NAVAN Technologies Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NAVAN Technologies's valuation, stock price, and market status.
